Treatment of mice with a ligand binding blocking anti-CD28 monoclonal antibody improves healing after myocardial infarction | PLOS ONE
![Anta", "Block", "Neutra"...but Who Are They? - Innovative antibodies against haptens and transmembrane proteins Anta", "Block", "Neutra"...but Who Are They? - Innovative antibodies against haptens and transmembrane proteins](https://image.jimcdn.com/app/cms/image/transf/none/path/s913ff347a6964b90/image/i6682f6b7804e7d27/version/1581671872/image.gif)
Anta", "Block", "Neutra"...but Who Are They? - Innovative antibodies against haptens and transmembrane proteins
![Cancers | Free Full-Text | CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific Antibodies Cancers | Free Full-Text | CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific Antibodies](https://pub.mdpi-res.com/cancers/cancers-13-04596/article_deploy/html/images/cancers-13-04596-ag.png?1631697501)
Cancers | Free Full-Text | CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific Antibodies
![Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy: Molecular Therapy Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy: Molecular Therapy](https://www.cell.com/cms/attachment/5bae4dff-da23-4111-a60c-25201932bc78/fx1.jpg)
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy: Molecular Therapy
![Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells - ScienceDirect Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0092867420306206-fx1.jpg)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells - ScienceDirect
![Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abe0240/asset/3b997df7-b697-4764-9a89-698714b29aff/assets/graphic/abe0240-f1.jpeg)
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology
![Frontiers | Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS Frontiers | Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS](https://www.frontiersin.org/files/Articles/709994/fimmu-12-709994-HTML-r2/image_m/fimmu-12-709994-g001.jpg)
Frontiers | Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS
![A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2 - Cai - 2022 - Advanced Science - Wiley Online Library A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2 - Cai - 2022 - Advanced Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3ac8d08f-0377-431a-be6c-43c145137e5a/advs3189-gra-0001-m.jpg?trick=1676794140319)
A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2 - Cai - 2022 - Advanced Science - Wiley Online Library
![Exploiting a chink in the armor: engineering broadly neutralizing monoclonal antibodies for SARS-like viruses | Signal Transduction and Targeted Therapy Exploiting a chink in the armor: engineering broadly neutralizing monoclonal antibodies for SARS-like viruses | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-021-00661-w/MediaObjects/41392_2021_661_Fig1_HTML.png)
Exploiting a chink in the armor: engineering broadly neutralizing monoclonal antibodies for SARS-like viruses | Signal Transduction and Targeted Therapy
![A Neutralizing Antibody-Conjugated Photothermal Nanoparticle Captures and Inactivates SARS-CoV-2 | bioRxiv A Neutralizing Antibody-Conjugated Photothermal Nanoparticle Captures and Inactivates SARS-CoV-2 | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/11/30/2020.11.30.404624/F1.large.jpg)